ChinaBio(R) LLC Release: China's Prescription Drug Market to Reach $315 Billion in 2020
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
August 2, 2013 -- GlobalData projects China’s prescription drug market will expand at a 26% compound annual growth rate to $315 billion in 2020, up from $48 billion last year. One of the drivers is China’s investment in drug R&D. GlobalData also believes the growth will take place because of (not in spite of) price pressures being exerted by China’s government. By increasing affordability, less-expensive products will expand the market and more than make up for lower unit prices, says the company. More details....
Help employers find you! Check out all the jobs and post your resume.
by Richard Daverman, PhD
August 2, 2013 -- GlobalData projects China’s prescription drug market will expand at a 26% compound annual growth rate to $315 billion in 2020, up from $48 billion last year. One of the drivers is China’s investment in drug R&D. GlobalData also believes the growth will take place because of (not in spite of) price pressures being exerted by China’s government. By increasing affordability, less-expensive products will expand the market and more than make up for lower unit prices, says the company. More details....
Help employers find you! Check out all the jobs and post your resume.